Outputs (2)

Bioinformatic and experimental data pertaining to the role of the NLRP3 inflammasome in ovarian cancer (2024)
Journal Article
Ashmore, A., Balasubramanian, B., Phillips, A., Asher, V., Bali, A., Ordóñez-Morán, P., & Khan, R. (2024). Bioinformatic and experimental data pertaining to the role of the NLRP3 inflammasome in ovarian cancer. Journal of Cancer Research and Clinical Oncology, 150(11), https://doi.org/10.1007/s00432-024-05988-9

The Nod-Like Receptor (NLR) family pyrin domain containing 3 (NLRP3) inflammasome plays a role in regulating inflammatory signaling and is a well-established contributor to pyroptotic cell death. It has been investigated extensively in cancer but the... Read More about Bioinformatic and experimental data pertaining to the role of the NLRP3 inflammasome in ovarian cancer.

Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma (2023)
Journal Article
Balasubramanian, B., Yacqub-Usman, K., Venkatraman, S., Myint, K. Z., Juengsamarn, J., Sarkhampee, P., Lertsawatvicha, N., Sripa, J., Kuakpaetoon, T., Suriyonplengsaeng, C., Wongprasert, K., Grabowska, A. M., Bates, D. O., Janvilisri, T., & Tohtong, R. (2023). Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma. Cancers, 15(9), Article 2528. https://doi.org/10.3390/cancers15092528

Cholangiocarcinoma (CCA) is an architecturally complex tumour with high heterogeneity. Discovery at later stages makes treatment challenging. However, the lack of early detection methodologies and the asymptomatic nature of CCA make early diagnosis m... Read More about Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma.